Terns Pharmaceuticals, Inc. - COM (TERN)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
65.6M
Holdings value Q2 2024
$447M
Value change Q2 2024
+$18.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
124
Number of buys Q2 2024
32
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.71M $14.3M +$4.07M $8.34 31
2024 Q2 65.6M $447M +$18.1M $6.81 124
2024 Q1 63.1M $414M -$2.69M $6.56 111
2023 Q4 63.6M $413M +$16.8M $6.49 102
2023 Q3 61.3M $308M +$5.82M $5.03 91
2023 Q2 57.7M $505M +$31.7M $8.75 103
2023 Q1 53.2M $630M +$46.2M $11.84 79
2022 Q4 49.7M $506M +$199M $10.18 65
2022 Q3 30.2M $178M +$107M $5.89 43
2022 Q2 14.7M $36.5M -$6.46M $2.48 37
2022 Q1 16.8M $50M -$1.39M $2.97 43
2021 Q4 16.5M $117M -$4.53M $7.07 37
2021 Q3 16.7M $174M +$980K $10.42 33
2021 Q2 16.6M $204M -$24.8M $12.26 36
2021 Q1 17.9M $394M +$393M $22.00 41